Synthetic Biologics Inc. (SYN) is priced at $0.53 after the most recent trading session. At the very opening of the session, the stock price was $0.58 and reached a high price of $0.58, prior to closing the session it reached the value of $0.57. The stock touched a low price of $0.50.
Recently in News on April 28, 2021, Synthetic Biologics to Report 2021 First Quarter Operational Highlights and Financial Results on May 5, 2021. — Conference Call Scheduled for Wednesday, May 5, 2021 at 4:30 p.m. ET –. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Synthetic Biologics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.7000 on 01/05/21, with the lowest value was $0.3830 for the same time period, recorded on 01/04/21.
Synthetic Biologics Inc. (SYN) full year performance was 59.52%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Synthetic Biologics Inc. shares are logging -68.75% during the 52-week period from high price, and 110.38% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.25 and $1.70.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 5450148 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Synthetic Biologics Inc. (SYN) recorded performance in the market was 38.69%, having the revenues showcasing -34.34% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 68.87M, as it employees total of 10 workers.
The Analysts eye on Synthetic Biologics Inc. (SYN)
During the last month, 0 analysts gave the Synthetic Biologics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.6743, with a change in the price was noted +0.1512. In a similar fashion, Synthetic Biologics Inc. posted a movement of +39.79% for the period of last 100 days, recording 15,475,596 in trading volumes.
Technical rundown of Synthetic Biologics Inc. (SYN)
Raw Stochastic average of Synthetic Biologics Inc. in the period of last 50 days is set at 13.48%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 26.61%. In the last 20 days, the company’s Stochastic %K was 35.75% and its Stochastic %D was recorded 41.97%.
Considering, the past performance of Synthetic Biologics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 38.69%. Additionally, trading for the stock in the period of the last six months notably improved by 71.24%, alongside a boost of 59.52% for the period of the last 12 months. The shares increased approximately by -9.04% in the 7-day charts and went up by -25.24% in the period of the last 30 days. Common stock shares were lifted by -34.34% during last recorded quarter.